DexCom had one patents in blockchain during Q2 2024. DexCom Inc filed a patent for an artificial pancreas system utilizing machine learning to continuously monitor glucose levels and deliver insulin doses to maintain glucose within a target range. The system includes a wearable glucose monitoring device, insulin delivery system, and computing device. The algorithm adjusts insulin doses based on glucose measurements and updates over time for improved effectiveness. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom had no grants in blockchain as a theme in Q2 2024.
Recent Patents
Application: Machine learning in an artificial pancreas (Patent ID: US20240148284A1)
The patent filed by DexCom Inc. describes the use of machine learning in an artificial pancreas system, which includes a wearable glucose monitoring device, an insulin delivery system, and a computing device. The wearable device continuously provides glucose measurements, while the computing device runs an artificial pancreas algorithm to determine insulin doses based on these measurements to maintain glucose levels within a target range. The algorithm is updated over time based on the effectiveness of the insulin doses. The patent also details a method for generating encrypted messages for requesting insulin delivery and communicating these messages between applications on the computing device and the insulin delivery system.
The patent claims outline a method for generating encrypted messages for insulin delivery requests, specifying the encryption process, communication between applications, and details of the delivery request. It also describes a computing device with applications for generating and communicating these encrypted messages, as well as computer-readable storage media storing instructions for performing these operations. Additionally, the patent includes an apparatus with encryption and communication means for generating and transmitting encrypted messages related to insulin delivery requests. These claims provide a detailed framework for implementing the artificial pancreas system described in the patent, emphasizing secure and efficient communication between the components involved in managing glucose levels.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
